Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY), Onyx Pharmaceuticals, Inc. (ONXX): Will ASCO Unlock Big Value in This Cancer Drug Class?

Page 2 of 2

There’s a lot more where that came from
This is just the tip of the iceberg with regard to the wealth of knowledge this annual conference brings. If you’re someone who’s been touched directly or indirectly by cancer, or are an investor looking for the latest and greatest innovations in the biotechnology and pharmaceutical sector, then stay tuned, because there’s a lot more data on the way!

The article Will ASCO Unlock Big Value in This Cancer Drug Class? originally appeared on Fool.com and is written by Sean Williams.

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2